Why Is YD Bio Limited Ordinary Shares (YDES) Up 16% Today?
Biotech's biggest mover today
YD Bio Limited Ordinary Shares is the biggest Biotech gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
The move
YDES trades at $6.73, up +16.2% on the session, with a market capitalisation of $476.7 million.
Volume is 0.7 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.
Against its 52-week range of $1.70 to $22.00, today's price sits 25% of the way up it.
What can be sourced
The record shows open-market insider buying on file within the last 90 days.
None of that is proof of causation. A filing or a target change that lands near a move is context, and the market routinely moves on neither.
What it does do is separate a move with something behind it from one with nothing.
| Metric | Value | Context |
|---|---|---|
| Change today | +16.2% | Biotech average +2.4% |
| Volume | 207,610 | 0.7x the 30-day average |
| Market cap | $476.7 million | Biotechnology |
| Range | $1.70 – $22.00 | 52 weeks |
What insiders have been doing
3 open-market insider transactions are on file for the last 90 days.
Insider activity before a move is the one piece of context that carries money behind it rather than an opinion.
It is also disclosed late, so proximity to today's move should not be read as foreknowledge.
| Metric | Value | Context |
|---|---|---|
| Change today | +16.2% | Biotech average +2.4% |
| Volume | 207,610 | 0.7x the 30-day average |
| Market cap | $476.7 million | Biotechnology |
| Range | $1.70 – $22.00 | 52 weeks |
The bottom line
A move with something on the record behind it. Whether it holds is a different question. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.